Day 1 - Wednesday, 16 September 2020
Liverpool Course 2020
Related Enduring Materials
Enduring Materials
Opening session - 16:00
16:00 CEST
Opening of the Virtual Program: Welcome and Goals
Session 1 -
Chair
16:10 CEST
DDIs in Acutely Sick Patients
16:35 CEST
COVID-19, Me and Clinical Pharmacology
Session 2 -
Oana Săndulescu, MD, PhD
Chair
Discussion
17:25 CEST
Clinical Case: Contraception, Pregnancy, Women's Health
Carol Davila University of Medicine and Pharmacy / National Institute for Infectious Diseases "Prof.Dr. Matei Bals", Romania
17:45 CEST
Clinical Case: Switching Patients - Including for DDIs
18:05 CEST
Clinical Cases: Recent DDIs Case Conundrums
Overview
Welcome
Designed and developed by renowned experts in the field of HIV care and pharmacology, The Liverpool Course aims to educate participants on key concepts in clinical pharmacology and drug-drug interactions, that remain a major consideration in the management of people living with HIV. It is organized in collaboration with the University of Liverpool and the leading experts who developed the Liverpool HIV drug interactions checker, a comprehensive drug-drug-interaction resource freely available to healthcare practitioners worldwide.
Program Chairs 2020
General Information
Meeting Objectives
This meeting aims to:
- Reinforce and develop the understanding of key clinical pharmacology concepts among junior colleagues in the fields of infectious diseases and hepatology (clinicians, pharmacists, academics, industry colleagues etc.)
- Improve clinical pharmacology education and thereby the quality of patient care.
- Educate healthcare professionals on how to use the Liverpool Drug Interaction Resources in their clinical practice.
- Increase knowledge and confidence among healthcare professionals through practical examples of the Liverpool Drug Interactions Resources and discussion of case studies tailored to the local needs.
- Reinforce and develop the understanding of key clinical pharmacology concepts among junior colleagues in the fields of infectious diseases and hepatology (clinicians, pharmacists, academics, industry colleagues etc.)
- Improve clinical pharmacology education and thereby the quality of patient care.
- Educate healthcare professionals on how to use the Liverpool Drug Interaction Resources in their clinical practice.
- Increase knowledge and confidence among healthcare professionals through practical examples of the Liverpool Drug Interactions Resources and discussion of case studies tailored to the local needs.
Learning Objectives
After participating in this activity, participants will be able to:
- Describe in detail the terms pharmacodynamics and pharmacokinetics.
- Define what is meant by clinically significant DDI and discuss DDI mechanisms.
- Use the Liverpool DDI Resource with confidence in their daily practice.
- Identify the potential of DDIs of ARVs and DAAs and use this information to improve their decision making in daily practice.
- Describe in detail the terms pharmacodynamics and pharmacokinetics.
- Define what is meant by clinically significant DDI and discuss DDI mechanisms.
- Use the Liverpool DDI Resource with confidence in their daily practice.
- Identify the potential of DDIs of ARVs and DAAs and use this information to improve their decision making in daily practice.
Practical Information
Certificate of Attendance
A certificate of attendance was sent to participants that successfully completed the program and post-meeting survey.
Language
The official language of the meeting was English.
Translation was not provided.
Translation was not provided.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Support
Corporate Support
The Clinical Pharmacology and Antiviral Therapy: The Liverpool Course is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Language
Related Programs
